Skip to main content
. Author manuscript; available in PMC: 2018 Sep 19.
Published in final edited form as: Circulation. 2017 Jul 7;136(12):1087–1098. doi: 10.1161/CIRCULATIONAHA.117.027067

Table 5. Cost-Effectiveness relative to Next Broadest Strategy, by Sex.

Males ATP III ACC-AHA Age/Sex-Based
Total Additional Persons Acted On 6.11 m 7.37 m 15.9 m
Total Cost -$7.75 b -$4.07 b -$8.02 b
 Treatment costs $5.85 b $7.33 b $6.87 b
 Screening costs $1.85 b $2.23 b $1.48 b
 Savings from events averted -$13.6 b -$11.4 b -$14.9 b
Incident CHD Events Averted 249,000 162,000 263,000
QALYs Saved 178,000 124,600 158,000
Lives Saved 42,900 28,400 27,700
Total Cost per QALY (ICER) Cost-saving Cost-saving Cost-saving
NNT per QALY 35 60 101
NNT per Life Saved 204 260 574

Females ATP III ACC-AHA Age/Sex-Based

Total Additional Persons Acted On 2.65 m 4.91 m 13.0 m
Total Cost -$2.97 b $219 m -$3.43 b
 Treatment costs $2.44 b $5.98 b $6.58 b
 Screening costs $800 m $1.48 b $1.21 b
 Savings from events averted -$5.41 b -$5.76 b -$10.0 b
Incident CHD Events Averted 92,100 74,500 158,000
QALYs Saved 74,900 58,600 110,000
Lives Saved 12,800 14,700 21,400
Total Cost per QALY (ICER) Cost-saving $3,400 Cost-saving
NNT per QALY 36 84 118
NNT per Life Saved 206 334 609